Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+9.6%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$72.7B
AUM Growth
+$7.54B
(+12%)
Cap. Flow
-$4.12B
Cap. Flow
% of AUM
-5.67%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
2,622
New
253
Increased
940
Reduced
728
Closed
298
Top Buys
| 1 |
Crown Castle
CCI
|
+$544M |
| 2 |
Procter & Gamble
PG
|
+$350M |
| 3 |
CSX Corp
CSX
|
+$329M |
| 4 |
NVIDIA
NVDA
|
+$233M |
| 5 |
GE Aerospace
GE
|
+$200M |
Top Sells
| 1 |
NetEase
NTES
|
+$433M |
| 2 |
HEICO
HEI
|
+$339M |
| 3 |
American Electric Power
AEP
|
+$337M |
| 4 |
Alibaba
BABA
|
+$309M |
| 5 |
Prologis
PLD
|
+$308M |
Sector Composition
| 1 | Technology | 27.05% |
| 2 | Financials | 13.73% |
| 3 | Industrials | 12.09% |
| 4 | Healthcare | 10.45% |
| 5 | Consumer Discretionary | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Zai Lab
ZLAB
$3.16B
| $73K | ﹤0.01% |
2,092
-139
| -6% | -$4.85K |
|
1727
iRhythm Technologies
IRTC
$5.85B
| $72K | ﹤0.01% |
+468
| New | +$72K |
|
1728
iShares Short Treasury Bond ETF
SHV
$20.7B
| – | – |
0
| – | -$72K |
|
1729
TG Therapeutics
TGTX
$5.05B
| $72K | ﹤0.01% |
2,027
-4,454
| -69% | -$158K |
|
|
TLN
1730
Talen Energy Corporation Common Stock
TLN
$18.4B
| $72K | ﹤0.01% |
248
| – | – |
|
1731
Sprinklr
CXM
$1.88B
| $71K | ﹤0.01% |
8,463
+8,135
| +2,480% | +$68.2K |
|
|
ARES.PRB
1732
Ares Management Corporation 6.75% Series B Mandatory Convertible Preferred Stock
ARES.PRB
$1.65B
| $71K | ﹤0.01% |
1,346
| – | – |
|
1733
A-Mark Precious Metals
AMRK
$592M
| $70K | ﹤0.01% |
3,192
+172
| +6% | +$3.77K |
|
1734
Celestica
CLS
$29.1B
| $70K | ﹤0.01% |
454
-413
| -48% | -$63.7K |
|
1735
iShares S&P 500 Growth ETF
IVW
$65B
| $70K | ﹤0.01% |
640
| – | – |
|
1736
Monro
MNRO
$507M
| $70K | ﹤0.01% |
+4,733
| New | +$70K |
|
1737
Quanex
NX
$697M
| $70K | ﹤0.01% |
3,749
-14,279
| -79% | -$267K |
|
1738
CPI Card Group
PMTS
$165M
| $69K | ﹤0.01% |
2,928
+1,467
| +100% | +$34.6K |
|
1739
CBIZ
CBZ
$3.01B
| $68K | ﹤0.01% |
960
+32
| +3% | +$2.27K |
|
1740
California Resources
CRC
$4.42B
| $68K | ﹤0.01% |
1,494
+6
| +0.4% | +$273 |
|
1741
DT Midstream
DTM
$10.9B
| $68K | ﹤0.01% |
621
+166
| +36% | +$18.2K |
|
1742
BlackLine
BL
$3.32B
| $67K | ﹤0.01% |
1,195
-288
| -19% | -$16.1K |
|
1743
Cytokinetics
CYTK
$6.22B
| $67K | ﹤0.01% |
2,055
-34,113
| -94% | -$1.11M |
|
1744
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.17B
| $67K | ﹤0.01% |
1,485
-1,466
| -50% | -$66.1K |
|
1745
Helen of Troy
HELE
$550M
| $67K | ﹤0.01% |
+2,368
| New | +$67K |
|
1746
Planet Fitness
PLNT
$8.52B
| $67K | ﹤0.01% |
617
-853
| -58% | -$92.6K |
|
1747
International Seaways
INSW
$2.28B
| $66K | ﹤0.01% |
1,811
-54,552
| -97% | -$1.99M |
|
1748
MDU Resources
MDU
$3.36B
| $66K | ﹤0.01% |
+4,014
| New | +$66K |
|
1749
Syndax Pharmaceuticals
SNDX
$1.36B
| $66K | ﹤0.01% |
+7,142
| New | +$66K |
|
1750
Harley-Davidson
HOG
$3.65B
| $65K | ﹤0.01% |
2,777
-22
| -0.8% | -$515 |
|